Journal of pharmaceutical sciences最新文献

筛选
英文 中文
Corrigendum to “Eliminating liquid chromatography-induced methionine oxidation of monoclonal antibodies using high-concentration TCEP injections: The “anTCEPtic” column cleaning method” [Journal of Pharmaceutical Sciences Volume 115, Issue 6, June 2026, 104298] “使用高浓度TCEP注射剂消除液相色谱诱导的单克隆抗体蛋氨酸氧化:“anTCEPtic”柱清洗方法”的更正[Journal of Pharmaceutical Sciences, vol . 115, Issue 6, June 2026, 104298]。
IF 3.9 3区 医学
Journal of pharmaceutical sciences Pub Date : 2026-09-01 Epub Date: 2026-09-22 DOI: 10.1016/j.xphs.2026.104344
Andrew Kleinberg, Joy Yoon, Yuan Mao, Ning Li
{"title":"Corrigendum to “Eliminating liquid chromatography-induced methionine oxidation of monoclonal antibodies using high-concentration TCEP injections: The “anTCEPtic” column cleaning method” [Journal of Pharmaceutical Sciences Volume 115, Issue 6, June 2026, 104298]","authors":"Andrew Kleinberg, Joy Yoon, Yuan Mao, Ning Li","doi":"10.1016/j.xphs.2026.104344","DOIUrl":"10.1016/j.xphs.2026.104344","url":null,"abstract":"","PeriodicalId":16741,"journal":{"name":"Journal of pharmaceutical sciences","volume":"115 9","pages":"Article 104344"},"PeriodicalIF":3.9,"publicationDate":"2026-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149025261","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Reply to comments on “Comprehensive stress study on recombinant adeno-associated virus vectors: Evaluating the capabilities of established analytical techniques” 答复关于“重组腺相关病毒载体的综合应激研究:评价现有分析技术的能力”的意见。
IF 3.9 3区 医学
Journal of pharmaceutical sciences Pub Date : 2026-09-01 Epub Date: 2026-06-06 DOI: 10.1016/j.xphs.2026.104354
Jakob Heckel, Lukas Bongers, David Naylor, Ole Schmidt, Raphael Ruppert, Marco Thomann, Florian Semmelmann, Angie Kirchner, Alexandra H.E. Machado, Markus Haindl, Michael Leiss, Jürgen Hubbuch, Tobias Graf
{"title":"Reply to comments on “Comprehensive stress study on recombinant adeno-associated virus vectors: Evaluating the capabilities of established analytical techniques”","authors":"Jakob Heckel, Lukas Bongers, David Naylor, Ole Schmidt, Raphael Ruppert, Marco Thomann, Florian Semmelmann, Angie Kirchner, Alexandra H.E. Machado, Markus Haindl, Michael Leiss, Jürgen Hubbuch, Tobias Graf","doi":"10.1016/j.xphs.2026.104354","DOIUrl":"10.1016/j.xphs.2026.104354","url":null,"abstract":"","PeriodicalId":16741,"journal":{"name":"Journal of pharmaceutical sciences","volume":"115 9","pages":"Article 104354"},"PeriodicalIF":3.9,"publicationDate":"2026-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148194914","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Response to comment on “A quantitative metric of immune responses with applications in vaccines, cancer immunity, autoimmunity, and anti-drug antibody monitoring” 对“在疫苗、癌症免疫、自身免疫和抗药物抗体监测中应用的免疫反应定量指标”评论的答复。
IF 3.9 3区 医学
Journal of pharmaceutical sciences Pub Date : 2026-09-01 Epub Date: 2026-05-16 DOI: 10.1016/j.xphs.2026.104331
Indiwari Gopallawa, Surendra Chavan, Arvind Goswami, Vibha Jawa, Narendra Chirmule
{"title":"Response to comment on “A quantitative metric of immune responses with applications in vaccines, cancer immunity, autoimmunity, and anti-drug antibody monitoring”","authors":"Indiwari Gopallawa, Surendra Chavan, Arvind Goswami, Vibha Jawa, Narendra Chirmule","doi":"10.1016/j.xphs.2026.104331","DOIUrl":"10.1016/j.xphs.2026.104331","url":null,"abstract":"","PeriodicalId":16741,"journal":{"name":"Journal of pharmaceutical sciences","volume":"115 9","pages":"Article 104331"},"PeriodicalIF":3.9,"publicationDate":"2026-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147963977","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Comment from Ailani et al on “Comprehensive stress study on recombinant adeno-associated virus vectors: Evaluating the capabilities of established analytical techniques” Ailani等人对“重组腺相关病毒载体的综合应激研究:评估现有分析技术的能力”的评论。
IF 3.9 3区 医学
Journal of pharmaceutical sciences Pub Date : 2026-09-01 Epub Date: 2026-06-06 DOI: 10.1016/j.xphs.2026.104352
Tanmay Ailani, Reenoo Jauhari, Anjna Rani, Rajesh Singh
{"title":"Comment from Ailani et al on “Comprehensive stress study on recombinant adeno-associated virus vectors: Evaluating the capabilities of established analytical techniques”","authors":"Tanmay Ailani, Reenoo Jauhari, Anjna Rani, Rajesh Singh","doi":"10.1016/j.xphs.2026.104352","DOIUrl":"10.1016/j.xphs.2026.104352","url":null,"abstract":"","PeriodicalId":16741,"journal":{"name":"Journal of pharmaceutical sciences","volume":"115 9","pages":"Article 104352"},"PeriodicalIF":3.9,"publicationDate":"2026-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148194866","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Reply to comment on “Multidisciplinary exploratory survey: Initial insights into biologic drug handling and regulatory perspectives among healthcare professionals” 回复对“多学科探索性调查:卫生保健专业人员对生物药物处理和监管观点的初步见解”的评论。
IF 3.9 3区 医学
Journal of pharmaceutical sciences Pub Date : 2026-09-01 Epub Date: 2026-05-22 DOI: 10.1016/j.xphs.2026.104343
Mattias Paulsson, Lara Nonis, Stanley Kwok
{"title":"Reply to comment on “Multidisciplinary exploratory survey: Initial insights into biologic drug handling and regulatory perspectives among healthcare professionals”","authors":"Mattias Paulsson, Lara Nonis, Stanley Kwok","doi":"10.1016/j.xphs.2026.104343","DOIUrl":"10.1016/j.xphs.2026.104343","url":null,"abstract":"","PeriodicalId":16741,"journal":{"name":"Journal of pharmaceutical sciences","volume":"115 9","pages":"Article 104343"},"PeriodicalIF":3.9,"publicationDate":"2026-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148005614","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Response to the letter regarding “nano-enabled targeted transdermal therapy for pain management in cervical cancer” 回应有关“纳米靶向经皮疗法治疗子宫颈癌疼痛”的函件。
IF 3.9 3区 医学
Journal of pharmaceutical sciences Pub Date : 2026-09-01 Epub Date: 2026-07-16 DOI: 10.1016/j.xphs.2026.104422
Beatrice Odei-Mensah, Samson A Adeyemi, Yahya Essop Choonara
{"title":"Response to the letter regarding “nano-enabled targeted transdermal therapy for pain management in cervical cancer”","authors":"Beatrice Odei-Mensah, Samson A Adeyemi, Yahya Essop Choonara","doi":"10.1016/j.xphs.2026.104422","DOIUrl":"10.1016/j.xphs.2026.104422","url":null,"abstract":"","PeriodicalId":16741,"journal":{"name":"Journal of pharmaceutical sciences","volume":"115 9","pages":"Article 104422"},"PeriodicalIF":3.9,"publicationDate":"2026-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148471277","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Reply letter to original letter: Comment on "Identifying and mitigating risks during biologic drug product manufacturing: A case study using computational fluid dynamics". 对原信的回复:关于“识别和减轻生物药品生产过程中的风险:使用计算流体动力学的案例研究”的评论。
IF 3.9 3区 医学
Journal of pharmaceutical sciences Pub Date : 2026-08-17 DOI: 10.1016/j.xphs.2026.104463
Sheetal Pai-Wechsung, James Morgan Harris, Fawziya Ali, Parag Kolhe, Advait Badkar
{"title":"Reply letter to original letter: Comment on \"Identifying and mitigating risks during biologic drug product manufacturing: A case study using computational fluid dynamics\".","authors":"Sheetal Pai-Wechsung, James Morgan Harris, Fawziya Ali, Parag Kolhe, Advait Badkar","doi":"10.1016/j.xphs.2026.104463","DOIUrl":"10.1016/j.xphs.2026.104463","url":null,"abstract":"","PeriodicalId":16741,"journal":{"name":"Journal of pharmaceutical sciences","volume":" ","pages":"104463"},"PeriodicalIF":3.9,"publicationDate":"2026-08-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148794672","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Comment on "Identifying and Mitigating Risks During Biologic Drug Product Manufacturing: A Case Study Using Computational Fluid Dynamics". 对“识别和降低生物药品生产过程中的风险:使用计算流体动力学的案例研究”的评论。
IF 3.9 3区 医学
Journal of pharmaceutical sciences Pub Date : 2026-08-17 DOI: 10.1016/j.xphs.2026.104462
Shaik Mohammed Yusuf, Md Abdul Sattar, Ravichandra Sharabu
{"title":"Comment on \"Identifying and Mitigating Risks During Biologic Drug Product Manufacturing: A Case Study Using Computational Fluid Dynamics\".","authors":"Shaik Mohammed Yusuf, Md Abdul Sattar, Ravichandra Sharabu","doi":"10.1016/j.xphs.2026.104462","DOIUrl":"https://doi.org/10.1016/j.xphs.2026.104462","url":null,"abstract":"","PeriodicalId":16741,"journal":{"name":"Journal of pharmaceutical sciences","volume":" ","pages":"104462"},"PeriodicalIF":3.9,"publicationDate":"2026-08-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148794582","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Biophysical investigations into the impact of crystallization conditions on monoclonal antibody properties and purification. 生物物理研究结晶条件对单克隆抗体性质和纯化的影响。
IF 3.9 3区 医学
Journal of pharmaceutical sciences Pub Date : 2026-08-12 DOI: 10.1016/j.xphs.2026.104459
Divya Chandra, Sanjeev Agarwal, Siddhi Patel, Sunitha Kandula
{"title":"Biophysical investigations into the impact of crystallization conditions on monoclonal antibody properties and purification.","authors":"Divya Chandra, Sanjeev Agarwal, Siddhi Patel, Sunitha Kandula","doi":"10.1016/j.xphs.2026.104459","DOIUrl":"10.1016/j.xphs.2026.104459","url":null,"abstract":"<p><p>Crystallization of monoclonal antibodies (mAbs) is a challenging problem given their large size and inherent structural complexity. Thousands of conditions need to be screened to arrive at a promising crystallization hit. Historically, crystallization has been successfully applied for preparative-scale purification and manufacturing of small molecules but rarely to produce mAbs, large globular proteins and peptides other than insulins. There is tremendous interest in the biopharmaceutical industry in exploring and implementing alternative strategies for the purification of biologics. One such non-platform, unit operation is crystallization. However, translatability across scales, robustness and amenability for large-scale processing are key challenges that need to be overcome to realize the success of crystallization as a unit operation in biomanufacturing. In this work, we take a biophysical characterization- driven approach to 1) elucidate differences between two unique crystallization conditions, previously identified via high-throughput screening, for a IgG4 mAb, and 2) demonstrate that the fundamental understanding generated from this biophysical characterization can enable a rational selection of crystallization conditions for bioprocessing applications. Results show that the crystallization conditions, both of which crystallize the mAb in two unique crystal structures, can impact the mAb structure and solution-state biophysical properties quite differently leading to significantly different outcomes in thermal and colloidal stability of the protein as well as in the purification of the mAb via crystallization as a unit operation. Second, this work highlights that co-crystallization of a large macromolecule like a mAb with a small molecule like caffeine can dramatically influence solution stability as well as impurity rejection. Third, and related to above we demonstrate that not all crystallization conditions that lead to structure elucidation are amenable for bioprocessing, as certain solution conditions can negatively impact protein solution stability and conformation, impurity co-precipitation thereby leading to lower impurity clearance from complex bioprocess feeds. For bioprocessing applications it is therefore critical to understand the impact of a condition on not just the pure mAb but also on the mAb in complex solutions alongside impurities.</p>","PeriodicalId":16741,"journal":{"name":"Journal of pharmaceutical sciences","volume":" ","pages":"104459"},"PeriodicalIF":3.9,"publicationDate":"2026-08-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148721928","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Editorial Advisory Board 编辑顾问委员会
IF 3.9 3区 医学
Journal of pharmaceutical sciences Pub Date : 2026-08-01 Epub Date: 2026-09-04 DOI: 10.1016/S0022-3549(26)00258-3
{"title":"Editorial Advisory Board","authors":"","doi":"10.1016/S0022-3549(26)00258-3","DOIUrl":"10.1016/S0022-3549(26)00258-3","url":null,"abstract":"","PeriodicalId":16741,"journal":{"name":"Journal of pharmaceutical sciences","volume":"115 8","pages":"Article 104409"},"PeriodicalIF":3.9,"publicationDate":"2026-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148935122","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信
小红书